Consistent with this assumption, it was shown that the enhanced protection against lymphoma in TNFR2–/– mice results from the recruitment, activation, AICD resistance, and subsequent prolonged survival at the tumor site of memory TNFR2–/– CD8+ T cell, specific to tumor-associated antigens (Kim J. et al., 2009). The gene discussed is CD8A; the disease is neoplasm.